Identifier |
20130212_nanos_posters_005 |
Title |
Visual Function and Freedom from Disease Activity in a Phase 3 Trial for Relapsing Multiple Sclerosis |
Creator |
Laura J. Balcer; Steven L. Galetta; Annie Zhang; Ryan Arnold |
Affiliation |
(LJB) (SLG) NYU School of Medicine, New York, NY; (AZ) (RA) Biogen-Idec, Cambridge, MA |
Subject |
Visual Function; Multiple Sclerosis; Low-Contrast Letter Acuity; Natalizumab |
Description |
In the phase 3 trial of natalizumab for relapsing MS (AFFIRM), low-contrast letter acuity (LCA) showed decreased probability of sustained visual loss in patients receiving active treatment. Freedom from clinical and radiological disease activity was also seen in 37% of treated patients over 2 years in AFFIRM. Given the importance of vision to overall functioning and quality of life in MS, we determined how freedom from disease activity might be associated with visual loss. |
Date |
2013-02-12 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2013 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2013: Poster Presentations |
Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6dn7brf |
Setname |
ehsl_novel_nam |
ID |
183354 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6dn7brf |